Javier Aragón

Javier Aragón

Auto-generated profile, based on publicly available information

Javier Aragón

Department of Chemical Engineering, Aragon Institute of Nanoscience (INA), University of Zaragoza, Campus Rio Ebro-Edificio I+D, C/Mariano Esquillor S/N, 50018 Zaragoza, Spain; Aragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Química Nova
Verified
Journal Article
Open access
PDF file
APAdrian Paz
Adrian Paz
DGDainelys Guadarrama
Dainelys Guadarrama
MLMónica López
Mónica López
JGJesús E. González
Jesús E. González
NGNayrim Brizuela Guerra
Nayrim Brizuela Guerra
JAJavier Aragón
Javier Aragón
In this study, bioactive hydroxyapatite nanoparticles were prepared by two different methods: wet chemical precipitation and biomimetic precipitation. The aim was to evaluate the morphology, particle-size, crystallinity and phases of the powders obtained by traditional wet chemical precipitation and the novel biomimetic precipitation using a supersaturated calcium solution. The nanoparticles were investigated by transmission electron microscopy, Fourier transform infrared spectroscopy and X-ray diffraction. The results revealed that the nanoparticles were formed by hydroxyapatite with a high crystallinity and controlled morphology. Additionally, it was found that the shape and size of the nanoparticles can be modified with each preparation method

1 November 2014 in Carbon
Verified
Journal Article
Closed access
JNJ. David Núñez
J. David Núñez
Ana M. BenitoAna M. Benito
Ana M. Benito
RGRamón González
Ramón González
JAJavier Aragón
Javier Aragón
Raul ArenalRaul Arenal
Raul Arenal
WMWolfgang K. Maser
Wolfgang K. Maser

10 April 2018 in Materials
Verified
Journal Article
Open access
PDF file
FBFareeha Batool
Fareeha Batool
DMDavid-Nicolas Morand
David-Nicolas Morand
LTlionel thomas
lionel thomas
IBIsaac Maximiliano Bugueno
Isaac Maximiliano Bugueno
JAJavier Aragon
Javier Aragon
Olivier HuckOlivier Huck
Olivier Huck
Ibuprofen (IBU) has been shown to improve periodontal treatment outcomes. The aim of this study was to develop a new anti-inflammatory scaffold by functionalizing an electrospun nanofibrous poly-ε-caprolactone membrane with IBU (IBU-PCL) and to evaluate its impact on periodontal inflammation, wound healing and regeneration in vitro and in vivo. IBU-PCL was synthesized through electrospinning. The effects of IBU-PCL on the proliferation and migration of epithelial cells (EC) and fibroblasts (FB) exposed to Porphyromonas gingivlais lipopolysaccharide (Pg-LPS) were evaluated through the AlamarBlue test and scratch assay, respectively. Anti-inflammatory and remodeling properties were investigated through Real time qPCR. Finally, the in vivo efficacy of the IBU-PCL membrane was assessed in an experimental periodontitis mouse model through histomorphometric analysis. The results showed that the anti-inflammatory effects of IBU on gingival cells were effectively amplified using the functionalized membrane. IBU-PCL reduced the proliferation and migration of cells challenged by Pg-LPS, as well as the expression of fibronectin-1, collagen-IV, integrin α3β1 and laminin-5. In vivo, the membranes significantly improved the clinical attachment and IBU-PCL also reduced inflammation-induced bone destruction. These data showed that the IBU-PCL membrane could efficiently and differentially control inflammatory and migratory gingival cell responses and potentially promote periodontal regeneration.

1 December 2018 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
JAJavier Aragón
Javier Aragón
Simona SalernoSimona Salerno
Simona Salerno
Loredana De BartoloLoredana De Bartolo
Loredana De Bartolo
Silvia IrustaSilvia Irusta
Silvia Irusta
GMGracia Mendoza
Gracia Mendoza

1 October 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JAJavier Aragón
Javier Aragón
CCClarinda Costa
Clarinda Costa
Isabel CoelhosoIsabel Coelhoso
Isabel Coelhoso
GMGracia Mendoza
Gracia Mendoza
AAAna Aguiar-Ricardo
Ana Aguiar-Ricardo
Silvia IrustaSilvia Irusta
Silvia Irusta

1 June 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
JAJavier Aragon
Javier Aragon
NNNuria Navascues
Nuria Navascues
GMGracia Mendoza
Gracia Mendoza
Silvia IrustaSilvia Irusta
Silvia Irusta
Core-shell polycaprolactone/polycaprolactone (PCL/PCL) and polycaprolactone/polyvinyl acetate (PCL/PVAc) electrospun fibers loaded with synthesized nanohydroxyapatite (HAn) were lased treated to create microporosity. The prepared materials were characterized by XRD, FTIR, TEM and SEM. Uniform and randomly oriented beadless fibrous structures were obtained in all cases. Fibers diameters were in the 150–300 nm range. Needle-like HAn nanoparticles with mean diameters of 20 nm and length of approximately 150 nm were mostly encase inside the fibers. Laser treated materials present micropores with diameters in the range 70–120 μm for PCL-HAn/PCL fibers and in the 50–90 μm range for PCL-HAn/PVAC material. Only samples containing HAn presented bioactivity after incubation during 30 days in simulated body fluid. All scaffolds presented high viability, very low mortality, and human osteoblast proliferation. Biocompatibility was increased by laser treatment due to the surface and porosity modification.